Mepolizumab, an IL-5 inhibitor, failed to alleviate moderate persistent asthma symptoms in a phase II trial of patients resistant to corticosteroids. References and Resources Flood-Page P, Swenson C,…
This study shows that compared with activation in the MTL, deactivation in the PMCs could be a more sensitive marker of early AD at functional MR imaging. References…
Douglas P. Slakey, MD, MPH, Regents Professor and Chair, Department of Surgery, Tulane University School of Medicine, discusses optimizing transplant patient outcomes. References and Resources American Liver Foundation…
